Aethlon Medical, Inc. (AEMD)

Aethlon Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	-	-	0.57	0.29	0.66	0.65
Revenue Growth (YoY)	-	-	95.21%	-55.37%	1.37%	183.15%
Gross Profit	-	-	0.57	0.29	0.66	0.65
Selling, General & Admin	11.77	11.77	12.47	10.72	8.55	6.58
Operating Expenses	11.77	11.77	12.47	10.72	8.55	6.58
Operating Income	-11.77	-11.77	-11.9	-10.42	-7.89	-5.93
Interest Expense	-	-	-	-	-	-0.05
Interest & Investment Income	0.43	0.43	0.01	-	-	-
EBT Excluding Unusual Items	-11.35	-11.35	-11.89	-10.42	-7.89	-5.98
Gain (Loss) on Sale of Assets	-	-	-0.14	-	-	-
Other Unusual Items	-0.86	-0.86	-	-	-	-0.4
Pretax Income	-12.21	-12.21	-12.03	-10.42	-7.89	-6.38
Earnings From Continuing Operations	-12.21	-12.21	-12.03	-10.42	-7.89	-6.38
Minority Interest in Earnings	-	-	-	0	0	0.01
Net Income	-12.21	-12.21	-12.03	-10.42	-7.89	-6.37
Net Income to Common	-12.21	-12.21	-12.03	-10.42	-7.89	-6.37
Shares Outstanding (Basic)	3	3	2	1	1	0
Shares Outstanding (Diluted)	3	3	2	1	1	0
Shares Change (YoY)	22.35%	22.35%	39.17%	22.05%	254.07%	182.61%
EPS (Basic)	-4.86	-4.86	-5.86	-7.06	-6.52	-18.67
EPS (Diluted)	-4.86	-4.86	-5.86	-7.06	-6.52	-18.67
Free Cash Flow	-10.38	-10.38	-11.45	-10.12	-6.82	-5.35
Free Cash Flow Per Share	-4.13	-4.13	-5.57	-6.86	-5.64	-15.66
Gross Margin	-	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-	-2072.05%	-3542.53%	-1197.31%	-912.04%
Free Cash Flow Margin	-	-	-1993.62%	-3439.01%	-1035.47%	-822.73%
EBITDA	-11.42	-11.42	-11.66	-10.3	-7.85	-5.9
D&A For EBITDA	0.36	0.36	0.24	0.12	0.04	0.03
EBIT	-11.77	-11.77	-11.9	-10.42	-7.89	-5.93
Revenue as Reported	-	-	0.57	0.29	0.66	0.65

Source: S&P Capital IQ. Standard template.